Column Capital Advisors’s GSK GSK Stock Holding History

Column Capital Advisors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$5.58K	Buy	154 +83	+117%	+$2.95K	﹤0.01%	589
2023 Q2	$2.53K	Hold	71	–	–	﹤0.01%	692
2023 Q1	$2.53K	Hold	71	–	–	﹤0.01%	703
2022 Q4	$2.5K	Buy	+71	New	+$2.37K	﹤0.01%	681
2022 Q3	–	Sell	-190	Closed	-$7.2K	–	728
2022 Q2	$10K	Hold	190	–	–	﹤0.01%	478
2022 Q1	$10K	Sell	190 -19	-9%	-$1.03K	﹤0.01%	503
2021 Q4	$12K	Buy	209 +25	+14%	+$1.3K	﹤0.01%	488
2021 Q3	$9K	Hold	184	–	–	﹤0.01%	481
2021 Q2	$9K	Buy	184 +88	+92%	+$4.23K	﹤0.01%	488
2021 Q1	$4K	Hold	96	–	–	﹤0.01%	552
2020 Q4	$4K	Sell	96 -88	-48%	-$4.04K	﹤0.01%	551
2020 Q3	$9K	Buy	184 +4	+2%	+$200	﹤0.01%	449
2020 Q2	$9K	Buy	180 +59	+49%	+$3.03K	﹤0.01%	488
2020 Q1	$6K	Buy	121 +30	+33%	+$1.6K	﹤0.01%	463
2019 Q4	$5K	Buy	+91	New	+$5.06K	﹤0.01%	525

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Primecap Management

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Royal Bank of Canada

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Arrowstreet Capital

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return